Hannah Musick on Muck Rack

Hannah Musick

Verified
Austin
As seen in: HMP Global, KTLA-TV (Los Angeles, CA), KDVR-TV (Denver, CO), WFLA-TV (Tampa, FL), KOIN-TV (Portland, OR), KRON-TV (San Francisco, CA), KTVI-TV (St. Louis, MO), WJW-TV (Cleveland, OH), WOOD-TV (Grand Rapids, MI), KXAN-TV (Austin, TX), WDAF-TV (Kansas City, MO) and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hannah

Contact Hannah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PBM Trade Group Challenges Illinois Drug Pricing Transparency Law on ERISA Grounds

|
By Hannah Musick Verified
| Pharmacy Learning Network Verified
Key Takeaways The Pharmaceutical Care Management Association (PCMA) has filed a federal lawsuit against Illinois challenging portions of the state’s Prescription Drug Affordability Act (PDAA), arguing that key pharmacy benefit manager (PBM) transparency and network-design provisions are preempted by the Employee Retirement Income Security Act (ERISA).
Open in Who Shared Issue with article?

Food Restrictions May Affect Adherence in Chronic Myeloid Leukemia

|
By Hannah Musick Verified
| First Report Managed Care Verified
News Key Clinical Summary More than half of patients with chronic myeloid leukemia (CML) taking tyrosine kinase inhibitors (TKIs) with food restrictions reported challenges adhering to dosing instructions. One-third of patients reported taking medication without following fasting requirements at least once during the previous month, and nearly 30% reported skipping a dose.
Open in Who Shared View Duplicates (699) Issue with article?

FDA Issues Class II Recall for Peritoneal Dialysis Solutions Due to Potential Sterility Breach

|
By Hannah Musick Verified
| Pharmacy Learning Network Verified
Key Takeaways The US Food and Drug Administration (FDA) is monitoring a voluntary, firm-initiated Class II recall of DELFLEX peritoneal dialysis solutions (1.5% and 2.5% dextrose, 2L 5-pack), involving over 80 000 bags distributed nationwide and identified across multiple lots including 25CU02007–25CU02009 and 25CU02002, 25CU02011–25CU02013. The recall was initiated by Fresenius Medical Care Holdings, Inc.
Open in Who Shared Issue with article?
See all 357 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified